73 results
Structural cardiac interventions in patients with heart failure
27 Aug 2024
The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).
Reviewer
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
01 Sep 2024
Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?
07 Apr 2024
Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.
Author
Cardiovascular intervention for chronic heart failure: where do we stand?
15 May 2024 – From EuroPCR 2024
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?
15 May 2024 – From EuroPCR 2024
Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...
Innovations in cardiovascular interventions for chronic heart failure: where are we in 2024?
15 May 2024 – From EuroPCR 2024
Is there an ongoing need for interventions in chronic heart failure? At ACC, a significant trial unveiled interatrial shunting. What does this mean for patients? Explore the devices involved in neuromodulation and considerations for patient discussions. Who might benefit from intravascular monitoring? Watch Giuseppe Rosano and...
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
Uncertainties in transcatheter tricuspid interventions
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video, you will:
- appreciate the challenges in patient assessment
- understand the need for adjunctive treatment targets
- acknowledge challenges in multivalvular disease
- Disease stages: criteria of futility and optimal response
- RV...
